Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schellong

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Leukemia|November 24, 2005
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trialsU Creutzig, M Zimmermann, J Ritter, et al.
Klinische Padiatrie|July 1, 1982
[BFM study 1975/81 for treatment of non-Hodgkin lymphoma of high malignancy in children and adolescents]S Müller-Weihrich, G Henze, A Jobke, et al.
Klinische Padiatrie|July 1, 1982
[Cooperative osteosarcoma study COSS-77: results after 4 years]K Winkler, G Beron, G Schellong, et al.
Klinische Padiatrie|May 1, 1983
[Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years]U Creutzig, J Ritter, H J Langermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study GroupG Schellong, R Pötter, J Brämswig, et al.
Klinische Padiatrie|June 4, 2004
The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studiesD Körholz, A Claviez, D Hasenclever, et al.
Klinische Padiatrie|September 23, 1998
[Multi-national therapy study for Hodgkin's disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years]W Dörffel, M Albrecht, H Lüders, et al.
Pediatric Blood & Cancer|June 6, 2013
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and AustriaC Rossig, H Juergens, M Schrappe, et al.
Klinische Padiatrie|July 1, 1982
[Acute lymphoblastic leukemia therapy study BFM 79/81 in children and adolescents: intensified reinduction therapy for patients with different risk for relapse]G Henze, H J Langermann, R Fengler, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Leukemia|November 24, 2005
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trialsU Creutzig, M Zimmermann, J Ritter, et al.
Klinische Padiatrie|July 1, 1982
[BFM study 1975/81 for treatment of non-Hodgkin lymphoma of high malignancy in children and adolescents]S Müller-Weihrich, G Henze, A Jobke, et al.
Klinische Padiatrie|July 1, 1982
[Cooperative osteosarcoma study COSS-77: results after 4 years]K Winkler, G Beron, G Schellong, et al.
Klinische Padiatrie|May 1, 1983
[Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years]U Creutzig, J Ritter, H J Langermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study GroupG Schellong, R Pötter, J Brämswig, et al.
Klinische Padiatrie|June 4, 2004
The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studiesD Körholz, A Claviez, D Hasenclever, et al.
Klinische Padiatrie|September 23, 1998
[Multi-national therapy study for Hodgkin's disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years]W Dörffel, M Albrecht, H Lüders, et al.
Pediatric Blood & Cancer|June 6, 2013
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and AustriaC Rossig, H Juergens, M Schrappe, et al.
Klinische Padiatrie|July 1, 1982
[Acute lymphoblastic leukemia therapy study BFM 79/81 in children and adolescents: intensified reinduction therapy for patients with different risk for relapse]G Henze, H J Langermann, R Fengler, et al.
Pageof 14